Results 91 to 100 of about 9,231 (134)

Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect. [PDF]

open access: yesJ Exp Med
Rhodehouse K   +22 more
europepmc   +1 more source

Genetic determinants of HIV-1 subtype C Nef-mediated SERINC3 down-regulation. [PDF]

open access: yesVirol J
Samlall N   +6 more
europepmc   +1 more source

Tat-specific antibodies associated with better HIV-associated motor function. [PDF]

open access: yesSci Rep
Hioe CE   +15 more
europepmc   +1 more source

The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4. [PDF]

open access: yesmBio
Tauzin A   +8 more
europepmc   +1 more source

Functional association between the nef gene product and gag-pol region of HIV-1.

open access: yesFunctional association between the nef gene product and gag-pol region of HIV-1.
openaire  

Biochemical and biological comparison of HIV-1 NEF and ras gene products

Virology, 1991
Human immunodeficiency virus type 1 (HIV-1) NEF protein has been reported to share certain biochemical and structural properties with known oncoproteins like src or rats. To determine whether this is a general property of NEF from various HIV isolates, three different NEF proteins were expressed in Escherichia coli using a thermoinducible expression ...
A R, Nebreda   +5 more
openaire   +2 more sources

Specificity of anti-Nef antibodies produced in mice immunized with DNA encoding the HIV-1 nef gene product

Vaccine, 1999
Mice immunized with plasmid DNA encoding Nef regulatory protein of human immunodeficiency virus type 1 developed high levels of anti-Nef antibodies. After 4 intramuscular injections of 100 microg plasmid DNA, anti-Nef antibodies reached titers up to 2 x 10(4). A significant specific antibody response was maintained for at least 16 months.
C, Moureau   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy